Clinical Trial Update: Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial studying the safety and tolerability of a ketogenic diet in amyotrophic lateral sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Johns Hopkins University | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: TERMINATED